Skip to content

Thromboplastin.Fs

by American Dade 510(k)

Active United States

510(k) K864272

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK864272 Date13 Nov 1986ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
GJS
Device Class
Class II
Regulation
21 CFR Part 864.7750
Advisory Committee
Hematology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 21 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

Thromboplastin.Fs is a test, time, prothrombin device used for in vitro coagulation studies. It is classified as a Class II medical device under product code GJS and regulation number 864.7750.

The device was cleared by the FDA through the traditional 510(k) pathway on November 13, 1986, under K864272, and is substantially equivalent to a predicate device. It is manufactured by American Dade in Santa Ana, California.

Other devices from American Dade

See all devices from American Dade →

Questions

AI-generated answers, 21 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is THROMBOPLASTIN.FS used for?

    THROMBOPLASTIN.FS is used for in vitro coagulation studies, specifically as a test, time, prothrombin device to measure prothrombin time in laboratory settings.

  • How is THROMBOPLASTIN.FS supplied and is it sterile or single-use?

    The device data does not specify supply format, sterility, or single-use/reuse status; these details are not included in the provided authorization or specifications.

  • What regulatory pathway was used for THROMBOPLASTIN.FS and when was it cleared?

    THROMBOPLASTIN.FS was cleared by the FDA through the traditional 510(k) pathway on November 13, 1986, under submission K864272, and found substantially equivalent to a predicate device.